£76.42

It has never been this cheap. We have no record of a lower price.

£76 today · cheaper than every other day in the last 3 months

Springer Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical
Generating forecast…
£76.42 £72.60 £74.13 £75.66 £77.18 £78.71 £80.24 11 August 2026 29 August 2026 16 September 2026 04 October 2026 22 October 2026
View at Amazon ↗

Price data last checked 18 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 73 days • 1 price levels

Days at Price
73 days 0 18 37 55 73 £76 Days at Price

Price Analysis

Most common price: £76 (73 days, 100.0%)

Price range: £76 - £76

Price levels: 1 different prices over 73 days

Description

There is now evidence that irreversible brain damage accumulates very early in the course of multiple sclerosis. This book reviews the main neurobiological, magnetic resonance imaging, and clinical aspects of the early phases of the dis ease. Mechanisms ofirreversible axonal damage and the role played by the inter action of glia and the axon are highlighted. In contrast to what was believed for a long time, the sufficient availability of oligodendrocyte precursor cells to promote remyelination in acute lesions has now been demonstrated. For reasons not understood, this remyelination process fails or does not start, particularly in the chronic stages ofthe disease. These findings emphasize the importance of the "milieu" changes induced by an inflammatory process in limiting remyelination. However, first indications are that part of this inflammatory process may have a neuroprotective effect. Pathological studies in multiple sclerosis have now clearly demonstrated that destructive processes may be followed by recovery phases in such a way that myelin may be morphologically and functionally reconstituted. These findings provide the rationale for early treatment and emphasize the importance of clinical trials in early multiple sclerosis. Early treatment is one of the most important aspects in multiple sclerosis today.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
28 September 2012
Listed Since
06 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments
86% match

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments

Springer

£80.67 23 Oct 2026
Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)
86% match

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Springer

£142.86 26 Oct 2026
Multiple Sclerosis: Practical Comprehensive Essentials
86% match

Multiple Sclerosis: Practical Comprehensive Essentials

£75.00 31 Oct 2026
From Basic Immunology to Immune-Mediated Demyelination (Topics in Neuroscience)
85% match

From Basic Immunology to Immune-Mediated Demyelination (Topics in Neuroscience)

Springer

£144.01 21 Oct 2026
Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)
84% match

Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)

Springer

£113.76 21 Oct 2026
Multiple Sclerosis: Diagnosis and Therapy
83% match

Multiple Sclerosis: Diagnosis and Therapy

Wiley

£75.27 20 Oct 2026
Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)
83% match

Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)

Springer

£109.24 28 Oct 2026
Molecular Biology of Multiple Sclerosis
83% match

Molecular Biology of Multiple Sclerosis

Wiley

Price unavailable
MRI Atlas of MS Lesions
82% match

MRI Atlas of MS Lesions

Springer

£80.67 28 Oct 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
81% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£108.15 30 Oct 2026
Neural and Neuroendocrine Mechanisms in Host Defense and Autoimmunity
81% match

Neural and Neuroendocrine Mechanisms in Host Defense and Autoimmunity

Springer

£113.76 24 Oct 2026
Neuron-Glia Interaction in Neuroinflammation: 7 (Advances in Neurobiology, 7)
81% match

Neuron-Glia Interaction in Neuroinflammation: 7 (Advances in Neurobiology, 7)

Springer

£123.63 24 Oct 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
80% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£107.23 04 Nov 2026
Multiple Sclerosis and Associated Demyelinating Disorders, An Issue of Neuroimaging Clinics of North America: Volume 34-3 (The Clinics: Radiology, Volume 34-3)
80% match

Multiple Sclerosis and Associated Demyelinating Disorders, An Issue of Neuroimaging Clinics of North America: Volume 34-3 (The Clinics: Radiology, Volume 34-3)

Elsevier

£66.20 22 Oct 2026
Neurodegenerative Disorders: A Clinical Guide
80% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 23 Oct 2026
Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses
80% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Elsevier

£137.99 21 Oct 2026
Neuroimmunology (Current Topics in Neurobiology)
79% match

Neuroimmunology (Current Topics in Neurobiology)

Springer

£77.89 22 Oct 2026
Schwann Cell Development and Pathology
79% match

Schwann Cell Development and Pathology

Springer

£80.67 23 Oct 2026
MR Imaging and Spectroscopy of Central Nervous System Infection
79% match

MR Imaging and Spectroscopy of Central Nervous System Infection

Springer

£113.76 24 Oct 2026
Protective and Pathological Immune Responses in the CNS: 265 (Current Topics in Microbiology and Immunology, 265)
79% match

Protective and Pathological Immune Responses in the CNS: 265 (Current Topics in Microbiology and Immunology, 265)

Springer

£110.63 21 Oct 2026
Therapeutic rTMS in Neurology: Principles, Evidence, and Practice Recommendations
79% match

Therapeutic rTMS in Neurology: Principles, Evidence, and Practice Recommendations

Springer

£95.74 20 Oct 2026
Neurological Disorders and Pregnancy
79% match

Neurological Disorders and Pregnancy

Elsevier

£110.00 31 Oct 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
78% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£97.49 17 Oct 2026
Metals and Oxidative Damage in Neurological Disorders
78% match

Metals and Oxidative Damage in Neurological Disorders

Springer

£145.59 23 Oct 2026